Edwards Lifesciences forward PE EW

Share price divided by analysts' consensus earnings for the next twelve months, since 2000.

Today, Oct 23, 2026: 28.3×
10-year median: 32.4×
Against its 10-year history: 13th; percentile: 0 is its lowest day, 100 its highest
10-year range: 23.4× to 54.4×
Peer median: 16.8×

Edwards Lifesciences' forward PE is 28.3× as of Oct 23, 2026.

That is below its ten-year median of 32.4×, lower than on 87% of days in the last ten years.

Over that time it ranged from 23.4× in Oct 2023 to 54.4× in Dec 2021.

The median for 7 medical device stocks of a similar size is 16.8×.

Forward PE over time

median 32.4×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	28.3×	26.0×	31.2×
2025	30.7×	27.5×	31.3×
2024	32.0×	25.0×	37.4×
2023	28.9×	23.4×	37.4×
2022	30.3×	27.8×	51.4×
2021	54.4×	37.7×	54.4×
2020	43.6×	34.3×	50.9×
2019	50.0×	30.1×	52.4×
2018	30.4×	28.4×	37.2×
2017	29.0×	26.2×	33.1×
2016	29.8×	26.5×	41.3×
2015	31.1×	29.3×	36.1×
2014	35.1×	24.1×	36.0×
2013	25.0×	23.3×	32.4×
2012	30.6×	28.8×	38.6×
2011	32.4×	28.7×	47.3×
2010	44.4×	25.7×	46.6×
2009	26.5×	19.9×	26.7×
2008	19.9×	7.0×	19.9×
2007	7.5×	7.5×	9.1×

Against its peers

Companies in Medical - Devices nearest Edwards Lifesciences' size, closest first, today.

Company	Forward PE
EWEdwards Lifesciences	28.3×
BSXBoston Scientific	14.1×
GEHCGE HealthCare Technologies	13.8×
DXCMDexCom	27.7×
SYKStryker	19.3×
MDTMedtronic	15.9×
ZBHZimmer Biomet	n/m
ABTAbbott Laboratories	17.7×
Peer median	16.8×

Where Edwards Lifesciences ranks

#41of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Edwards Lifesciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.